Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Chan‐Yen Tsai"'
Autor:
Wang-Da Liu, Po-Hao Feng, Chien-Yu Cheng, Chun-Liang Chou, Chih-Hsin Lee, Min-Chi Lu, Po-Yu Liu, Mei-Hui Lee, Chun-Hsing Liao, Mei-Chuan Chen, Cheng-Pin Chen, Shang-Fu Hsu, Yu-Tien Tzeng, Yi-Chun Lin, Tsong-Yih Ou, Albert Qin, Chan-Yen Tsai, Weichung Joe Shih, Kang-Yun Lee, Wang-Huei Sheng
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 7, Pp 1575-1588 (2024)
Abstract Introduction Ropeginterferon alfa-2b is a novel mono-pegylated proline-interferon. This clinical study aimed to evaluate its antiviral efficacy of ropeginterferon alfa-2b against SARS-CoV-2 infection. Methods This is a multicenter, randomize
Externí odkaz:
https://doaj.org/article/c4d086975f614f53bd26100305caa75e
Autor:
Ching-Chu Lo, Wan-Long Chuang, Hsing-Tao Kuo, Wei-Ming Chen, Albert Qin, Chan-Yen Tsai, Yi-Wen Huang, Chi-Yi Chen
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 1, Pp 55-61 (2024)
Aim: Ropeginterferon alfa-2b is a novel mono-pegylated proline-interferon. Its biweekly dosing schema has demonstrated tolerability and clinical efficacy for treating chronic hepatitis in previous clinical studies. This trial evaluates the pharmacoki
Externí odkaz:
https://doaj.org/article/9850b955695541f483e388e3a8fae2e8
Autor:
Chi‐Yi Chen, Wan‐Long Chuang, Albert Qin, Wen‐Hua Zhang, Li‐Ying Zhu, Guo‐Qiang Zhang, Jyh‐Jou Chen, Ching‐Chu Lo, Xinmin Zhou, Xiaorong Mao, Jia Shang, Hsing‐Tao Kuo, Wen Xie, Chien‐Hung Chen, Gin‐Ho Lo, Dae W Jun, Shuangsuo Dang, Chan‐Yen Tsai, Ting‐Fang Wang, Hsin‐Hui Lai, Kuan‐Chiao Tseng, Yi‐Wen Huang, Pei‐Jer Chen
Publikováno v:
JGH Open, Vol 6, Iss 11, Pp 782-791 (2022)
Abstract Background and Aim Ropeginterferon alfa‐2b is a novel mono‐pegylated, extra‐long‐acting interferon. It is administered infrequently and showed good tolerability and clinical activity for the chronic hepatitis B or C treatment in our
Externí odkaz:
https://doaj.org/article/b7057a2e69a042f3b15c1e087a8e6413
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 1, p 433 (2023)
Hepatocellular carcinoma (HCC) usually recurs after curative surgical resection. Currently, no approved adjuvant therapy has been shown to reduce HCC recurrence rates. In this study, the in vivo effect of sequential combination treatment with recombi
Externí odkaz:
https://doaj.org/article/835a14717f8741948f627b7bdaa154ec
Publikováno v:
Viruses, Vol 14, Iss 6, p 1128 (2022)
Ropeginterferon alfa-2b is a novel mono-pegylated and extra-long-acting interferon, being developed for the treatment of myeloproliferative neoplasm (MPN) and chronic viral hepatitis. It has a favorable pharmacokinetic profile and less frequent dosin
Externí odkaz:
https://doaj.org/article/4abf1c6fa0f64a48965bd8c4e540b72c
Autor:
Chan-Yen Tsai, 蔡昌晏
101
Embryonal brain tumors are a large group of malignant grade IV tumors in pediatric brain tumors. They are a group of heterogeneous tumors with characteristic of the presence of poorly differentiated stem-like cells and can be classified into
Embryonal brain tumors are a large group of malignant grade IV tumors in pediatric brain tumors. They are a group of heterogeneous tumors with characteristic of the presence of poorly differentiated stem-like cells and can be classified into
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/72347929435881066606
Autor:
Kuan-Yuan, Chen, Kang-Yun, Lee, Albert, Qin, Ching-Shan, Luo, Yun-Kai, Yeh, Jing-Quan, Zheng, Ching-Mei, Chen, Chan-Yen, Tsai, Sheena, Lin, Jason, Liao, Yi-Wen, Huang, Po-Hao, Feng
Publikováno v:
Advances in Therapy
Introduction This study, for the first time to our knowledge, evaluated the efficacy of ropeginterferon alfa-2b, a long-acting pegylated interferon (IFN)-alfa, in the treatment of COVID-19. Methods We retrospectively evaluated ropeginterferon alfa-2b
Autor:
Mei xia Wang, Albert Qin, Bo Song, Yi Wen Huang, Chung Wei Tsai, Chan Yen Tsai, William Wang, Chingleou Teng, Jingjing Zhang
Publikováno v:
Advances in Therapy. 38:4756-4770
Ropeginterferon alfa-2b is a novel mono-pegylated human recombinant interferon (IFN) with the addition of N-terminal proline covalently attached by a 40-kDa polyethylene (peg) moiety. The present study aimed to evaluate the pharmacokinetics (PK), pha
Autor:
Tzu-Hao Lin, Chan-Yen Tsai, Kun-Hsi Tsai, Jou-Kou Wang, Li-Chin Chen, Chui-Hsuan Cheng, Shih-Hau Fang, Wei-Chien Wang, Yu Tsao
Auscultation is the most efficient way to diagnose cardiovascular and respiratory diseases. To reach accurate diagnoses, a device must be able to recognize heart and lung sounds from various clinical situations. However, the recorded chest sounds are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33d80feaf3736451152edfc797441e79
Autor:
Jason C. Huang, Hsei-Wei Wang, Ming Chun Li, Jeng Kae Jiang, Yau Yun Jhang, Hui Yu Chuang, Chan Yen Tsai, Muh Hwa Yang
Publikováno v:
Oncotarget
// Hui-Yu Chuang 1 , Jeng-Kae Jiang 3, 4 , Muh-Hwa Yang 5, 6, 8, 10, 11 , Hsei-Wei Wang 2, 8, 9 , Ming-Chun Li 12 , Chan-Yen Tsai 2 , Yau-Yun Jhang 1 , Jason C. Huang 1, 13 1 Department of Biotechnology and Laboratory Science in Medicine, National Ya